This review article outlines the multifaceted approach required to reduce polypharmacy and to effectively manage, monitor and prevent comorbidities and maintain quality of life in older people (aged ≥50 years) living with HIV. This review is commissioned and funded by GlaxoSmithKline (NZ) Ltd.
Please login below to download this issue (PDF)